Food allergy drug developer Alladapt raised $119M in new funding By: Silicon Valley Business Journal via Business Journals June 22, 2022 at 18:52 PM EDT The funding comes as the Menlo Park company has begun a clinical trial and is building a manufacturing plant. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
